Your browser doesn't support javascript.
loading
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial.
Ray, Kausik K; Kallend, David; Leiter, Lawrence A; Raal, Frederick J; Koenig, Wolfgang; Jaros, Mark J; Schwartz, Gregory G; Landmesser, Ulf; Garcia Conde, Lorena; Wright, R Scott.
Affiliation
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, Reynolds Building, St Dunstans Road, London W6 8RP, UK.
  • Kallend D; DalCor Pharmaceuticals, Montreal, QC, Canada.
  • Leiter LA; LIB Therapeutics, Cincinnati, OH, USA.
  • Raal FJ; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Koenig W; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Jaros MJ; German Heart Centre, Technical University Munich, DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Schwartz GG; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
  • Landmesser U; Summit Analytical, Denver, CO, USA.
  • Garcia Conde L; Cardiology Division, University of Colorado School of Medicine, Aurora, CO, USA.
  • Wright RS; Department of Cardiology, Charité-University Medicine Berlin, Berlin Institute of Health (BIH), DZHK, Partner Site Berlin, Germany.
Eur Heart J ; 43(48): 5047-5057, 2022 12 21.
Article in En | MEDLINE | ID: mdl-36331315
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Anticholesteremic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Anticholesteremic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Heart J Year: 2022 Type: Article Affiliation country: United kingdom